Description

The 68 ANIRIDIA IOL is a specialized intraocular lens designed to address the unique needs of patients with aniridia and aphakia, often associated with cataract surgery. This innovative device serves a dual purpose, providing both functional and cosmetic correction by mimicking the natural iris.

Key Features

• Optic Design: The lens features a monofocal, refractive, spheric optic with added spherical aberration, enhancing visual performance. Its biconvex shape and customizable diaphragm size (ranging from 4.5 mm to 10 mm) allow for precise adaptation to individual patient anatomy.

• Cosmetic Matching: The peripheral region of the lens is available in various pigmentation options, closely resembling the natural iris. This feature, along with tinted variants, helps reduce photophobia and improve cosmetic outcomes.

Material and Biocompatibility

Crafted from highly biocompatible materials such as PEMA, PMMA, and flexible silicone, the lens ensures compatibility with the eye's natural environment. The foldable nature of the silicone allows for convenient implantation through injection.

Implantation and Fixation

The 68 ANIRIDIA IOL offers versatile fixation methods, including placement in the capsular bag or sulcus, with options for scleral fixation using 9-0 Prolene sutures. It requires a large incision (>10.0 mm), and manual loading is necessary as the lens is not preloaded.

Optical Properties

• Refractive Index: 1.49
• A Constant: 119.6 (for sclera-sutured fixation)
• ACD Constant: 5.37 or 5.90

These properties, along with UV protection, contribute to the lens's effectiveness, though it does not correct astigmatism or provide blue light control.

Clinical Benefits

The lens significantly reduces photophobia and glare while enhancing the cosmetic appearance of the eye. It is compatible with most intraocular lens models and supports a variety of surgical techniques, making it a versatile option for ophthalmic surgeons.

Customization and Compatibility

Available in diameters from 9.0 mm to 12.5 mm in 0.5 mm increments, the lens can be tailored to match the patient's iris defect precisely. Its design is supported by multiple peer-reviewed clinical studies, underscoring its effectiveness and reliability.

The 68 ANIRIDIA IOL stands out as a comprehensive solution for patients requiring both visual and aesthetic rehabilitation, backed by robust clinical evidence and adaptable surgical options.